Chinese Journal of Tissue Engineering Research ›› 2026, Vol. 30 ›› Issue (12): 2965-2974.doi: 10.12307/2026.660

Previous Articles     Next Articles

Glutamine regulates the effect of hormones on the apoptosis of bone microvascular endothelial cells

Zan Yongfeng, Song Keguan, Liu Yuda   

  1. The First Affiliated Hospital of Harbin Medical University, Harbin 150000, Heilongjiang Province, China
  • Received:2025-03-07 Accepted:2025-07-31 Online:2026-04-28 Published:2025-09-28
  • Contact: Song Keguan, Chief physician, The First Affiliated Hospital of Harbin Medical University, Harbin 150000, Heilongjiang Province, China
  • About author:Zan Yongfeng, MS candidate, The First Affiliated Hospital of Harbin Medical University, Harbin 150000, Heilongjiang Province, China
  • Supported by:
    Heilongjiang Renxin Bone Health Medical Relief Foundation Project, No. 2022HX031 (to SKG)

Abstract: BACKGROUND: Glucocorticoids can significantly inhibit the expression of proteins related to the phosphatidylinositol 3 kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) signaling pathway in bone microvascular endothelial cells, thereby triggering programmed cell death and necrosis. Glutamine has been shown to activate the PI3K/Akt/mTOR signaling pathway.
OBJECTIVE: To explore how glutamine regulates the effect of glucocorticoids on the apoptosis of bone microvascular endothelial cells.
METHODS: Bone microvascular endothelial cells were extracted from the femoral head tissues of Sprague-Dawley rats under aseptic conditions. Passage 3 bone microvascular endothelial cells were cultured for 12 hours and then divided into four groups: the control group was routinely cultured for 24 hours, the glucocorticoid group was cultured with methylprednisolone sodium succinate for 24 hours, the glucocorticoid+glutamine group was cultured with methylprednisolone sodium succinate for 12 hours and then with glutamine for 12 hours, and the glucocorticoid+glutamine+LY294002 group was cultured with methylprednisolone sodium succinate for 12 hours followed by addition of glutamine treatment for 6 hours and the PI3K/Akt signaling pathway inhibitor LY294002 for 6 hours. After culture, cell apoptosis was detected by AO-PI double fluorescence staining and Annexin V/PI double staining by flow cytometry; BCL-2, Bax, PI3K, Akt, mTOR mRNA expression was detected by RT-qPCR; and western blot was used to detect BCL-2, Bax, PI3K, Akt, mTOR, p-PI3K, p-Akt, and p-mTOR protein expression. 
RESULTS AND CONCLUSION: (1) The apoptosis rate was higher in the glucocorticoid group than in the control group and the glucocorticoid+glutamine group (P < 0.05), and the apoptosis rate was higher in the glucocorticoid+glutamine+LY294002 group than in the glucocorticoid+glutamine group (P < 0.05). (2) BCL-2, PI3K, Akt, mTOR mRNA expression in the glucocorticoid group was lower than that in the control group and glucocorticoid+glutamine group (P < 0.05), and Bax mRNA expression was higher than that in the control group and glucocorticoid+glutamine group (P < 0.05); BCL-2, PI3K, and mTOR expression in the glucocorticoid+glutamine+LY294002 group was lower than that in the glucocorticoid+glutamine group (P < 0.05), and Bax mRNA expression was higher than that in the glucocorticoid+glutamine group (P < 0.05). (3) BCL-2, PI3K, Akt, mTOR, p-PI3K, p-Akt, p-mTOR protein expression in the glucocorticoid group was lower than that in the control group and the glucocorticoid+glutamine group (P < 0.05), and Bax proteins were higher than that in the control group and the glucocorticoid+glutamine group (P < 0.05); BCL-2, PI3K, Akt, mTOR, p-PI3K, p-Akt, p-mTOR protein expression in the glucocorticoid+glutamine+LY294002 group was lower than that in the glucocorticoid+glutamine group (P < 0.05) and Bax protein expression was higher than that in the glucocorticoid+glutamine group (P < 0.05). To conclude, glutamine reduces glucocorticoid-induced apoptosis in bone microvascular endothelial cells through activation of the PI3K/Akt/mTOR signaling pathway.

Key words: glucocorticoid, apoptosis, steroid-induced osteonecrosis of the femoral head, glutamine, endothelial cells, LY294002, signaling pathway, femoral head

CLC Number: